CLINICAL_TRIALS trial_result · 2026-06-26

Clinical Trial Results: SPI-1005 for the Treatment of Meniere's Disease [Phase 3]

Phase 3 trial results for SPI-1005 in treating Meniere's disease have been completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Sound Pharmaceuticals, Incorporated | Conditions: Meniere Disease, Ménière | Phase 3 | Status: COMPLETED | Results posted: 2026-06-26